SEC Form 4 · accession 0000899243-18-028339
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vojo Vukovic
Officer — SVP, Chief Medical Officer
Period of report
Nov 5, 2018
Accepted (ET)
Nov 6, 2018 · 6:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.16 | Nov 5, 2018 | A | 150,000 | A | — | Nov 4, 2028 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1This option was granted on November 5, 2018. The shares underlying the option are scheduled to vest as to 25% of the shares on November 5, 2019 and thereafter in equal monthly installments through November 5, 2022.